WIENER KLINISCHE WOCHENSCHRIFT, vol.127, pp.274-282, 2015 (SCI-Expanded)
Background and aim Sarcoidosis is a multisystem disease of unknown origin. Determining the involvement and the response to the treatment is important. The aim of this study was to identify the effects of methylprednisolone and indomethacine on metabolic activity and pulmonary function test parameters in patients with sarcoidosis.